McCormick's Q1 earnings miss amid tariff pressures, but the company maintains its full-year outlook and emphasizes cost savings and strategic price adjustments.
HHS plans to close long COVID research office, raising concerns about future efforts to address the chronic condition.
McCormick's Q1 earnings miss amid tariff pressures, but the company maintains its full-year outlook and emphasizes cost savings and strategic price adjustments.
HHS plans to close long COVID research office, raising concerns about future efforts to address the chronic condition.